Brooke is an associate editor for The American Journal of Managed Care® (AJMC®). She joined AJMC in 2023, where she produces written content covering multiple disease states.
She has a BA in journalism from Seton Hall University. You can connect with Brooke on LinkedIn.
Study Highlights Differences in Cytoreduction's Impact on Survival Among Ovarian Cancer Subtypes
The association between residual tumor volume after primary cytoreduction and survival was less consistent in patients with low-grade serous ovarian carcinoma (LGSOC) compared with other histology types, highlighting variability in surgical outcomes across ovarian cancer subtypes.
Dr Ryan Jacobs Highlights Sustained Success in Patients With CLL Through 1-Year Treatment Plan
Ryan Jacobs, MD, of Atrium Health Levine Cancer Institute, explains that the phase 2 CAPTIVATE study's fixed-duration treatment cohort shows long-term progression-free survival for patients with chronic lymphocytic leukemia (CLL) who received the first-line treatment of ibrutinib and venetoclax.
Team Effort: Dr Brian Koffman Describes Multidisciplinary Care for Patients With CLL
Brian Koffman, MDCM, DCFP, FCFP, DABFP, MSEd, of CLL Society, details the comprehensive multidisciplinary support for patients with chronic lymphocytic leukemia (CLL) at the European Hematology Association (EHA) 2024 Congress.
High Rates of Inhaler Misuse Found Among Patients With COPD Using Soft Mist Inhalers
Misuse of soft mist inhalers (SMIs) is common among patients with chronic obstructive pulmonary disease (COPD), particularly those with low education levels, higher symptom scores, and a shorter disease duration.
Dr Surya Bhatt on Dupilumab's Promise in Reducing COPD Exacerbations, Enhancing Quality of Life
Surya Bhatt, MD, MSPH, of the University of Alabama at Birmingham, explained the phase 3 BOREAS and NOTUS trials demonstrated comparable safety profiles for dupilumab in treating patients with chronic obstructive pulmonary disease (COPD).
High Magnesium Depletion Scores Linked to Increased Mortality in US Patients With Hypertension
Having a higher magnesium depletion score (MDS) independently predicts increased all-cause and cardiovascular mortality risks in US patients with hypertension (HTN), emphasizing the importance of early HTN prevention and magnesium deficiency management.
Exploring the Importance of Biomarker Testing to Identify Genetic Variants, Correct Treatments
On this episode of Managed Care Cast, Kristine Ashcraft, president and founder of YouScript, explains the importance of biomarker testing to distribute proper treatments to patients and minimize adverse events.
Dr Thomas Hall Explores How Geographic, Socioeconomic Factors Affect Dermatological Outcomes
Thomas Hall, MD, FAAD, of US Dermatology Partners, explains that disparities in dermatological care arise from the uneven distribution of dermatologists, especially in rural areas, causing delayed diagnoses and higher health care costs.
Dr Surya Bhatt Highlights NOTUS Trial Findings, Promising Dupilumab Results
Surya Bhatt, MD, MSPH, of the University of Alabama at Birmingham, discussed the challenges of diagnosing chronic obstructive pulmonary disease (COPD) with type 2 inflammation, as well as the promising efficacy of dupilumab in treating this condition.
Exercise, Diet Interventions Boost Fat-Free Mass, Reduce Fatigue in Patients With OC
Exercise and dietary interventions reduced fatigue and improved both fat-free mass and physical functioning in patients with ovarian cancer (OC), but no significant differences in improvement were found between the intervention and control groups.
Surgery, Chemotherapy Considered Protective Survival Factors in Patients With OC, Liver Metastases
Surgery and chemotherapy significantly improved both overall survival (OS) and cancer-specific survival (CSS) in patients with liver metastases originating from ovarian cancer (OC), who generally face a poor prognosis with a 5-year survival rate of less than 30%.
Patients With COPD, PRISm at Increased All-Cause, Cause-Specific Mortality Risk
Patients with chronic obstructive pulmonary disease (COPD) and/or preserved ratio impaired spirometry (PRISm) have an increased risk of all-cause and cause-specific mortality, highlighting the need for better understanding of these conditions through increased spirometry data collection.